Back to ETFs
EquityHELX
Franklin Genomic Advancements E
Ticker
HELX
Asset Class
Equity
Assets Under Management
23.73M
Issuer
Franklin Templeton Investments
Inception Date
25-02-2020
Dividend Yield
0.39%
About This Fund
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Franklin Genomic Advancements E Price Chart
Loading chart…